Literature DB >> 12755810

The role of clinical pharmacology in optimizing antiretroviral therapy.

David J Back1, Saye H Khoo.   

Abstract

Mesh:

Year:  2003        PMID: 12755810      PMCID: PMC1884200          DOI: 10.1046/j.1365-2125.2003.01843.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

Review 1.  The pharmacogenomics of HIV therapy.

Authors:  M Pirmohamed; D J Back
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

Review 2.  Therapeutic drug monitoring in HIV infection: current status and future directions.

Authors:  David Back; Giorgio Gatti; Courtney Fletcher; Rodolphe Garaffo; Richard Haubrich; Richard Hoetelmans; Michael Kurowski; Andrew Luber; Concepta Merry; Carlo-Federico Perno
Journal:  AIDS       Date:  2002-03       Impact factor: 4.177

3.  Concentration-targeted therapy and the future of HIV management.

Authors:  Charles W Flexner; Stephen C Piscitelli
Journal:  AIDS       Date:  2002-03       Impact factor: 4.177

Review 4.  Critical issues in therapeutic drug monitoring of antiretroviral drugs.

Authors:  Rolf P G Van Heeswijk
Journal:  Ther Drug Monit       Date:  2002-06       Impact factor: 3.681

5.  The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.

Authors:  J Zhang; P Kuehl; E D Green; J W Touchman; P B Watkins; A Daly; S D Hall; P Maurel; M Relling; C Brimer; K Yasuda; S A Wrighton; M Hancock; R B Kim; S Strom; K Thummel; C G Russell; J R Hudson; E G Schuetz; M S Boguski
Journal:  Pharmacogenetics       Date:  2001-10

6.  Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

Authors:  Jacques Fellay; Catia Marzolini; Emma R Meaden; David J Back; Thierry Buclin; Jean Philippe Chave; Laurent A Decosterd; Hansjakob Furrer; Milos Opravil; Giuseppe Pantaleo; Dorota Retelska; Lidia Ruiz; Alfred H Schinkel; Pietro Vernazza; Chin B Eap; Amalio Telenti
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

7.  Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.

Authors:  B Ledergerber; M Egger; M Opravil; A Telenti; B Hirschel; M Battegay; P Vernazza; P Sudre; M Flepp; H Furrer; P Francioli; R Weber
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

8.  Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S.

Authors:  I Yuasa; K Umetsu; U Vogt; H Nakamura; E Nanba; N Tamaki; Y Irizawa
Journal:  Hum Genet       Date:  1997-03       Impact factor: 4.132

9.  Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients.

Authors:  Frank J Palella; Joan S Chmiel; Anne C Moorman; Scott D Holmberg
Journal:  AIDS       Date:  2002-08-16       Impact factor: 4.177

10.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

Authors:  S Hoffmeyer; O Burk; O von Richter; H P Arnold; J Brockmöller; A Johne; I Cascorbi; T Gerloff; I Roots; M Eichelbaum; U Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

  10 in total
  3 in total

Review 1.  Pharmacokinetics of antiretroviral therapy in HIV-1-infected children.

Authors:  Pieter L A Fraaij; Jeroen J A van Kampen; David M Burger; Ronald de Groot
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  HIV-positive nigerian adults harbor significantly higher serum lumefantrine levels than HIV-negative individuals seven days after treatment for Plasmodium falciparum infection.

Authors:  Ifeyinwa Chijioke-Nwauche; Albert van Wyk; Chijioke Nwauche; Khalid B Beshir; Harparkash Kaur; Colin J Sutherland
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

Review 3.  Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

Authors:  Matthieu Roustit; Malik Jlaiel; Pascale Leclercq; Françoise Stanke-Labesque
Journal:  Br J Clin Pharmacol       Date:  2008-05-15       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.